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Raman spectroscopy’s capability to provide meaningful composition predictions is
heavily reliant on a pre-processing step to remove insignificant spectral variation.
This is crucial in biofluid analysis. Widespread adoption of diagnostics using Raman
requires a robust model which can withstand routine spectra discrepancies due to
unavoidable variations such as age, diet, and medical background. A wealth of
pre-processing methods are available, and it is often up to trial-and-error or user
experience to select the method which gives the best results. This process can be
incredibly time consuming and inconsistent for multiple operators.
In this study we detail a method to analyze the statistical variability within a
set of training spectra and determine suitability to form a robust model. This
allows us to selectively qualify or exclude a pre-processing method, predetermine
robustness, and simultaneously identify the number of components which will form
the best predictive model. We demonstrate the ability of this technique to improve
predictive models of two artificial biological fluids.
Raman spectroscopy is ideal for noninvasive, nondestructive analysis. Routine
health monitoring which maximizes comfort is increasingly crucial, particularly in
epidemic-level diabetes diagnoses. High variability in spectra of biological samples
can hinder Raman’s adoption for these methods. Our technique allows the deci-
sion of optimal pre-treatment method to be determined for the operator; model
performance is no longer a function of user experience. We foresee this statistical
technique being an instrumental element to widening the adoption of Raman as a
monitoring tool in a field of biofluid analysis.
Keywords: Raman Spectroscopy, Quantiative Biological Analysis, Machine Learn-
ing, Pre-processing Methods, Chemometrics
I. INTRODUCTION
An enhancement in existing quantitative analysis capabilities for biofluids using Raman
spectroscopy has great potential to improve biomedical diagnostics and monitoring as well
as contribute to patient quality of life. Blood, saliva, tears and urine all contain a wealth of
vibrational information, which can inform health-care practitioners about a patient’s system
immunity, waste excretion, nutrient delivery, and many other vital aspects1. Most of these
fluids can be collected relatively non-invasively, which contributes to patient comfort during
routine or long-term testing. This is in contrast to clinical assessment, which is often the
standard technique for analysis and diagnosis, despite its reliance on heavily specialized
equipment and trained operators to interpret results.
There is currently a shortage in the range of diagnostic tools which can flexible to address
a range of biofluids, while being simultaneously portable, easy to implement and can be
programmed for rapid reliable predictions. Raman spectroscopy is an ideal tool for detailed
quantitative analysis of biofluids. It provides unparalleled chemical specificity with mini-
mal sample preparation, and can preserve the fluid under test for further analysis23. The
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2challenge associated with Raman approaches is their weak signal, when compared to lumi-
nescence. Enhancement techniques such as surface enhanced Raman or Coherent anti-stokes
Raman require cumbersome chemical preparation with limited repeatability or expensive,
complex instrumentation, respectively. Raman using liquid core waveguides (LCW) can be
a powerful technique to enhance the signal from biofluids, with no chemical preparation
necessary. Despite the enhancement that attainable using LCW of biofluids, an analyti-
cal technique capable of quantitatively handling the widely varied response obtained from
biofluids belonging to a range of patients is still lacking.
Quantitative analysis requires that we observe and monitor trends in features, such Ra-
man modes, within and across a range of spectra. However this can be prohibitive when
each spectrum contains several thousand data points. Principal component analysis (PCA)
is a widespread technique in spectroscopy and chemometrics to reduce the dimensionality
and facilitating the quantification of such information4. PCA forms a vector space for the
data set whose basis vectors are themselves mutually orthogonal, linear functions of the
original data, and which maximize variability within the set.
The basis vectors are functions of the data set and are excellent tools to reveal trends
which may not be apparent upon manual inspection. These trends can be put to use in
predictive multivariate linear regression models like principal component regression (PCR),
significantly simplifying and expediting quantitative analysis of Raman spectra.
However, there are limitations on PCA whose basis vectors are highly sensitive to outliers
in the data set and may unintentionally correlate with experimental artifacts such as a
fluorescent background, detector noise, and drift-based amplitude variations. The PCR’s
capability to repeatedly provide reliable and meaningful predictions can be significantly
hampered by the presence of these spectral features. Such features are omnipresent in
Raman spectra obtained from real-life biofluids. Correcting and accounting for artifacts is
of particular importance in biological analysis where samples are inherently variable from
one patient to the next5. Compensating for these aberrations with a pre-processing step
can drastically improve PCR’s ability to form a robust model. PCR also requires a decision
about how many basis vectors to include in the model. If too few are included, trends in
the data set may not be sufficiently characterized. Higher order basis vectors often describe
noise, so these should be excluded. The number of vectors must be optimized to minimize
computation time and artifact correlation while maximizing prediction accuracy.
In order to mitigate some of these limitations, cross-validation is a standard technique
to predict PCR model performance by assessing the response of a PCR model on different
spectra using varying combinations of basis vectors. Selecting the number of vectors may
be based on distributional assumptions about the training set or by measuring the degree
of fit. However, these methods can fail if the distribution is incorrect and may not describe
the model’s performance for new spectra67. The possible combinations of loading vectors
and pre-processing methods for cross-validation rapidly becomes prohibitive to assess, par-
ticularly for large data sets. The optimal pre-processing method for a training set can be
determined by trial and error, but this is not a generic or a robust approach and does not
indicate the suitability to future predictions. It also proves to be a lengthy process when
multiple techniques are being tested simultaneously89. As such, there is still a real lack of
a dependable, automated and sufficiently generic approach to render PCR immune from
its limitations and enable it to fulfill its power of quantitatively analyzing Raman spectra,
from real life biofluidic samples.
In this work we have developed a two step process to quickly determine the suitability
of pre-processing methods and output the optimal number of basis vectors for a robust
predictive model. For a given pre-processing method we perform cross-validation on a
known data set, and analyze the predicted residual matrix using a statistical F-test. F-tests
have previously been used in biological context to determine the number of significant factors
in a model, but not to determine pre-processing suitability10611. Our approach is validated
using the analysis of two fluids designed to mimic human tears and whole human blood.
The combination of LCWs and a statistical F-test to optimize the PCR model allows us
to reliably predict constituent concentrations in tertiary biological phantom solutions with
3a sensitivity exceeding 0.1 mg/mL, bringing the predictions into a diagnostically-relevant
range. To the best of our knowledge this is the first time statistical F-testing is being used
to determine the suitability of a pre-processing technique and simultaneously output the
optimal number of basis vectors for a predictive model.
II. FORMALISM OF PRINCIPAL COMPONENT REGRESSION
the relationship between PCs and the original data set is best illustrated by inspecting
Equation 1. Each spectrum in the set can be expressed as a linear sum of k principal
components, which are themselves the product of a basis or loading vector and an associated
weighting factor.
X = TPᵀ +E
= t1p
ᵀ
1 + ...+ tkp
ᵀ
k +E
(1)
P : Loading vectors (j × k)
T : Scores (i× k)
X : Spectra (i× j)
Expressing a data set with respect to its principal components presents us with the
opportunity to form a regression prediction model used to gain insight into another spectra’s
unknown composition. Throughout this discussion we will use the convention of upper-
case bold to denote matrices, lower-case bold for column vectors, and lower-case italics for
scalars. A superscript (ᵀ) is used to indicate the matrix or vector transpose. In this study
the predicted items in PCR are concentrations of an analyte, however the process is equally
applicable to a wide range of predictions such as solubility of peanut proteins, or positioning
error in GPS1213.
Two independent data sets are required for PCR: a reference set whose concentrations
are known, and a set whose concentrations are unknown. Starting with the data set with
known composition, the algorithm NIPALS (non-iterative partial least squares) is used to
obtain the weighting and loading vectors. Score, loading, and concentration matrices are
used as shown in equations 2 and 3 to obtain the regression coefficients and an estimation
for constituent concentrations (Cest)
14.
B =
TᵀC
TᵀT
(2)
Cest = BT
ᵀ
= B(XestP)
ᵀ (3)
B : Regression coefficients (q × k)
C : Known concentrations (q × i)
Cest : Estimated concentrations (q × r)
Xest : Spectra to be estimated (r × j)
Xest consists of r rows of independent spectra to be estimated. C contains q unique
species whose concentrations are to be calculated for Cest.
4III. MATERIALS AND METHODS
Here we shall describe the techniques of pre-processing, principal component determina-
tion, and cross-validation. These methods on their own are commonplace in the process-
ing of Raman spectra. However the decision of which technique is most suitable for pre-
processing requires considerable manual intervention, and thus the model’s robustness will
vary with the operator. Our method seeks to rectify this. We have used the pre-processing
techniques described in section III A in conjunction with statistical analysis methods in
section III C to develop a system which can optimize the pre-processing method without
user input. With these adaptations multiple users with varied experience levels can operate
a Raman analysis system with the confidence that their results hold significance. Many
biofluids can be processed under a single system without requiring manual calibration for
each set of results. Raman spectra of a biofluid collected on multiple systems can be used
together for one common diagnostic analysis, regardless of spectral variations caused small
changes in measurement conditions. We will demonstrate in this study that the technique
can repeatedly generate a robust predictive model, opening up exciting new opportunities
for the adoption of Raman spectroscopy in biological applications.
A. Preprocessing Techniques
Intensity Normalization
Amplitude normalization is often required prior to PCR to ensure consistency between
spectra. Between experiments, or even within one, slight changes in path-length or focal
point can manifest as differences in the amplitude of Raman peaks, negatively impacting the
results of PCR. Three commonly-used techniques to accomplish amplitude normalization
are scaling based on reference peak height, by standard normal variate transform (SNV)
(equation 4), or with the robust normal variate transform (RNV) (equation 5)15.
xadj =
x− µ(x)
σ(x)
(4)
SNV centers each spectrum in a set by its mean (µ) and scales it by its standard deviation
(σ). RNV centers and scales spectral data similarly, but makes an additional assumption
about its distribution. RNV was introduced as the solution to a closure problem. Closure,
in statistics, indicates that the sum of the set is equal to a certain number16. Therefore if
one value in the set increases, another must decrease to compensate. Each SNV spectrum
is mean-centered therefore its sum is zero and the set is closed. This can have the unwanted
effect of introducing artificial variance in an attempt to maintain closure16. RNV modifies
SNV by using percentiles (denoted pct) rather than means:
xadj =
x− pct(x)
σ[x ≤ pct(x)] (5)
An immediately apparent benefit to RNV is reduced influence of outliers. If the distri-
bution of response measurements for one variable is skewed in any way, the percentile is
a more robust descriptor of tendencies within the data set than the standard deviation17.
The percentile must be optimized in order for RNV to provide the best possible predic-
tion model; several techniques have been proposed to accomplish this and can be found in
literature16.
5Smoothing
Noise in the Raman signal can greatly affect the robustness of of a PCR model. We
desire a model which describes the Raman response, not the artifacts within it. Savitzky-
Golay (SG) is the best-known smoothing algorithm15. This method uses a moving window
of points which are successively fitted to a polynomial using the method of least squares.
Each point in the data set is evaluated and replaced with the value of the polynomial which
is the best fit based on the group of points evaluated18. The SG algorithm is well-suited to
removing noise, but can affect the spectrum in some points where sharp peaks are present.
The size of the moving-window and degree of the polynomial must therefore be optimized
on a case-to-case basis.
Differentiation
Systematic trends in a spectrum may be compensated for with differentiation. A constant
offset baseline is removed with the first derivative, linearly sloped baseline via the second
derivative, and so on15.
B. Calculation of Principal Components
If all PCs are desired, singular value decomposition is a computationally-efficient option.
When only the PCs of highest variance are desired, NIPALS has been shown to reduce
computation time19. NIPALS iteratively calculates each set of weights and loadings by
repeatedly regressing X on to a weighting matrix to obtain improved loading vectors, and
then regressing the X on to the improved loading vectors to obtain improved weightings.
Once the algorithm converges, the calculated PC is subtracted from X and the residual
data matrix is used to calculate successive components20. NIPALS may be terminated once
sufficient variance is described14.
C. Cross-Validation and Statistical F-Testing
Higher order PCs can represent noise or experimental artifacts within the data set, and
may not pose a positive contribution to the predictive model. Including these variables
introduces risks such as over-fitting to the parameter being predicted, or compromising the
model’s performance when applied to new samples21. We have chosen leave-one-out cross
validation to assess the predictive ability of PCR models. It is an excellent tool to account
for sample-specific errors and generate a reproducible predictive model22. Though it can
be computationally expensive in large data sets we shall demonstrate how the addition
of a statistical F-test can pre-emptively reject pre-treatment methods which lead to an
ineffective model.
Leave-one-out cross-validation is initiated with the matrix X, calibration spectra whose
concentrations are known. In turn each spectra is removed and the remaining i− 1 spectra
are used to predict the composition of removed spectra using 1 through i − 2 PCs. Ex-
ceeding i− 2 principal components presents the possibility that each spectra forms its own
basis vector, negating PCA dimension reduction. Following PCR, error is calculated using
Predicted Residual Sum of Squares (PRESS):
PRESS =
q∑
n=1
(Cest,n −Cn)2 (6)
Full leave-one-out cross-validation yields a matrix S sized i × i − 2 of PRESS values on
which we perform a statistical F-test to compare variability within one PC to that between
6different PCs17. An F-test gives a statistical measure of whether differences in prediction
are significant or simply due to sampling. This is essential during cross-validation in order
to assess the model’s suitability.
Significance determination begins with the null hypothesis (H0) that the mean PRESS
values for each PC are equal and an alternative hypothesis (Ha) that they are not all equal.
A measure of the variability within each PC is first calculated using a modified sum of
squares for error (SSE) (equation 7). A measurement for the variation within S caused by
using different PCs is explained using the sum of squares for treatments (SST) (equation
8).
SSE =
i−1∑
n=1
i−2∑
m=1
(Sn,m − Sm)2 (7)
SST = (i− 2)
i−2∑
m=1
(Sm − S)2 (8)
The F-statistic (equation 9) is determined from SST and SSE, after normalizing each
factor by their respective degrees of freedom.
F =
SST/(i− 3)
SSE
(9)
Statistical significance of F is determined by referencing a table of values for a chosen
significance level α, the probability of erroneously rejecting the null hypothesis. If F > Fα
we reject H0. To perform F-test computations using equations 7-9 and determine signifi-
cance we are using MatLAB’s anova1 function from the Statistics and Machine Learning
Toolbox.
When a different number of PCs leads to a statistically significant difference in concen-
tration prediction (F > Fα), we single out the PCs which show significance relative to the
PC with highest prediction error. From this subset we select the PC with combined lowest
error in prediction and highest measure of significance. In the case that we fail to reject
H0 the user is alerted and we opt for the PC with lowest sum of PRESS values. We have
observed that failure to reject H0 is not a function of the data set itself. Instead it indicates
an inappropriate selection in pre-processing treatment. Thus this technique allows us to im-
mediately reject a pre-processing method and rapidly proceed to the processing techniques
most suited to the particular data set. Figure 1 illustrates this point. Both plots begin
with an identical data set. The data in the top plot is pre-processed using first derivative
and the data in the bottom plot using baseline removal and RNV at the 90th percentile. A
difference in pre-treatment method leads the second plot to significantly better predictions
as a function of the number of PCs which is mirrored in the resulting prediction accuracy.
Variability in the PRESS matrix will occur in two dimensions: for each file as the unknown
in the cross validation model there will be variation as a function of the number of PCs,
and within each PC thee will be variation as a function of the file which is used as the
unknown. We demonstrate this variability using a box plot. A filled rectangle shows the
interquartile range (IQR), the area between 25th and 75th percentiles, with the median
value marked within. A thin solid line extends to the minimum and maximum points which
are not considered outliers, which are depicted as open circles and defined by the criteria
that they lie further from the 25th or 75 percentile than 1.5 times the IQR17 All F-tests are
evaluated at significance level α = 0.05.
D. Spectra Collection
All Raman spectra were collected on an Horiba HR800 Spectrometer using a grating of
600 grooves/mm and an excitation laser centered at 633 nm. Laser power was 17 mW.
7FIG. 1. Variation within PRESS values for each number of PCs, caused by using a different
Raman spectra as the unknown in a cross-validation training model. Top: Spectra pre-processed
using the first derivative. Little change is observed in PRESS values as the number of PCs is altered,
indicating that the pre-processing method is ill-suited for a PCR model. Bottom: Preprocessing
using baseline removal and RNV at the 90th percentile. As the number of PCs is altered, PRESS
values consistently improve significantly. We expect that this pre-treatment method will yield a
well-performing PCR model.
FIG. 2. Comparison of Raman spectra of isopropyl alcohol collected with two different methods.
The LCW provides substantial enhancement under otherwise identical collection conditions.
Exposure times ranged from 60s to 240s with 1-3 acquisitions depending on desired SNR.
Fluidic sample collection was assisted and enhanced by a custom-built microfluidic device
with integrated Teflon capillary tube LCW. Details on liquid-core waveguide enhancement
of fluidic samples can be found in our previous research233.
Figure 2 illustrates the enhancement that a LCW can provide over conventional Raman
collection using a drop of sample. The microfluidic device eliminates evaporation, stabiliz-
ing the focal point and enabling us to be confident that the biofluid composition remains
unchanged for the duration of lengthy collection times. Our microfluidic LCW technique,
shown in figure 3, has allowed us to obtain a collection of high quality Raman spectra
to demonstrate our statistical technique and its applicability to physiologically relevant
biofluid analysis. Further reading on LCWs can be found in previous publications233.
8FIG. 3. LCW Spectrometer configuration
E. Biofluids
Raman spectra of biological samples are inherently variable not only between patients,
but within an individual due factors such as collection method or hydration state242526.
Abnormal concentrations of certain analytes are diagnostically relevant, so it is crucial
that we are able to compensate for these variations with a high degree of reproducibility
in order to accurately assess one patient relative to a population. Two artificial biofluid
phantoms were constructed for our experiments which satisfied either diagnostic relevance
or optical property matching, and which eliminated special training, handling, and disposal
requirements.
Human tears contain upwards of 400 unique proteins27. Variations in the concentration
of the protein lysozyme in particular have been shown to be relevant for the diagnosis
of herpes simplex virus, Sjoren’s syndrome, and kerato-conjunctivitis2829. In addition to
proteins, tears contain diagnostically relevant substances such as glucose. Diabetes is one
of the most prevalent diseases among developed nations, affecting hundreds of millions
worldwide30. It requires regular blood glucose monitoring, and facilitating this process has
been the source of extensive research31. Glucose is known to be difficult to detect in Raman
spectroscopy due to its small scattering cross-section32. We demonstrate in this experiment
that our liquid core waveguide microfluidic device, when used together with this statistical
analysis method, allows us to repeatedly and accurately predict physiologically relevant
concentrations of glucose and lysozyme in human tears.
Samples to mimic human tears were comprised of lysozyme and glucose dissolved in
deionized water (DIW), each at physiologically relevant levels. This range for lysozyme
is between 0 and 10 mg/ml, and for glucose it is between 0 and 1 mg/mL282427. D-
(+)-Glucose (G8270) and Lysozyme from chicken egg white (62970) were purchased from
Sigma-Aldrich. DIW was obtained from a Milli-Q in the Bahen Prototyping facility at
Toronto Nanofabrication Center (TNFC).
To simplify blood analysis we have focused on the optical properties of whole blood.
Diagnostics using whole blood minimizes the dependence on specialized equipment to pre-
process the sample, but detecting low-concentration analytes is severely compromised due
to red blood cell’s strong scattering coefficient2.
As a substitute for whole-blood we have used a 20% Intralipid fat emulsion (I141) pur-
chased from Sigma-Aldrich. The scattering coefficient of this media is a good match to that
of whole blood3334. Additionally, intralipid is inexpensive, non-toxic, and requires no spe-
cial handling or disposal, making it a suitable phantom for this proof-of-concept study. Two
solutes were used within intralipid: DIW and isopropyl alcohol (IPA). DIW was obtained
from TNFC, and IPA (190764) from Sigma-Aldrich. These solutes were selected due to
their availability, in order to demonstrate that our liquid core waveguide microfluidic device
allows us to detect increasingly lower concentrations within an opaque solution, and the
statistical analysis method reliably distinguishes different Raman modes when more than
one analyte is present.
Enhanced Raman spectra of biofluids are an ideal candidate to demonstrate our improved
PCR robustness algorithm. Fluorescent baseline (figure 4 top) and amplitude variations
9FIG. 4. Top: Two spectra of artifical tears, with composition varying by 1 mg/mL glucose and
0.5 mg/mL lysozyme. Baseline drift requires correction. Bottom: Two spectra of intralipid,
with composition varying by 0.4% IPA and 0.4% DIW, collected with different exposure times.
Amplitudes require normalization.
(figure 4 bottom ) are omnipresent in the Raman spectra of biofluids. Including them in
a PCR model in raw form may worsen predictions by correlating insignificant amplitude
variations, despite their potential to significantly strengthen the model if artefacts can be
corrected. Using the methods described in section III our method successfully combats
these key challenges which may prevent Raman spectroscopy from being considered as a
candidate for reliable diagnostics.
IV. RESULTS AND DISCUSSION
We aim to demonstrate that our technique is capable of reliably quantifying analytes in
artificial tears and intralipid solutions. We shall compare PCR model performance in the
case where pre-treatment produces statistical significance in cross-validation, to the case
where a pre-processing method is not found to produce significance. Within each set of
Raman specta one spectum acted as the unknown and cross-validation was performed on
the remainder, in order to predict the suitability of different pre-processing methods. To
demonstrate the algorithm’s efficacy we plot the PRESS values compared to the actual
residual sum of squares (RSS) of the unknown spectra. In each case analyzed we shall
demonstrate that our technique is superior at identifying a suitable a pre-treatment method
and number of PCs for an optimal PCR model.
Figure 6 depicts a case in which the pre-processing method shows statistical significance;
cross validation model accurately predicts true RSS performance. The solutions from which
these Raman spectrum were generated were designed to mimic optical properties of whole
human blood and comprised intralipid, DIW and IPA. Preprocessing treatments applied
were RNV at the 75th percentile after baseline removal. The data set contains 27 spectra,
some of which were collected with longer exposure times, so amplitude normalization is
necessary. Within the PRESS matrix each PC was cross-validated with 26 spectra. The
box plot predicts an improvement of up to one order of magnitude of the median residual
prediction. In addition, there are never more than four outliers for each PC during cross-
validation. This data set passed the cross-validation test, and our F-test algorithm returned
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FIG. 5. The flow chart of pre-processing statistical significance algorithm
FIG. 6. Intralipid solution, pre-processed with RNV (percentile 75) and baseline removal. PRESS
values of cross-validation using 26 spectra (top) display significant variation with the number of
PCs, and identifies 22 PCs for the regression model which is a minima in observed RSS (bottom).
22 as the optimal number of PCs for the data set based on the PRESS matrix significance.
Actual composition for this solution is 5% IPA, 85% Intralipid, 10% Deionized Water.
Predicted concentrations with the model are 5.1%, 84.6%, 9.5% respectively. The optimal
PC value returned is indeed the minimum within actual RSS values, so we confirm the
validity of the model formed with this pre-processing treatment.
Figure 7 depicts a case in which the pre-processing method fails the significance test;
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FIG. 7. Intralipid solution, pre-processed with SG smoothing and 2 derivatives. PRESS values
of cross-validation using 26 spectra (top) do not significantly improve or worsen with the number
of PCs. Choosing the PC with minimum sum of PRESS values does not lead to a model which
minimizes observed RSS (bottom).
cross validation model fails to return true RSS performance. A similar data set from figure
6 was used for this case; a different Raman spectra as the unknown and cross-validation
was performed with the remaining 26 spectra in the set. Preprocessing methods were SG
smoothing and 2 derivatives. The box plot shows a greater number of outliers than figure
6, and the median residual prediction improves by only one half order of magnitude as
the number of PCs are varied. This pre-processing method did not pass the significance
test. We select the PC with lowest sum of PRESS values (10) as the optimal number for the
model, but using 6, 7, 9, or 12 PCs would have yielded lower RSS. Actual concentrations for
this solution are 10% IPA, 85% Intralipid, 5% Deionized Water. Predicted concentrations
with the model are 10.3%, 85.4%, 5.3%. The minimum sum of PRESS values is not a
minima within actual RSS values; this pre-processing method’s cross-validation model fails
to identify four other PC values which would optimize the PCR model.
A second case in which the pre-processing method shows statistical significance and cross
validation predicts true RSS performance is illustrated in Figure 8. 40 samples were de-
signed to mimic human tears and consisted of DIW with varying concentrations of lysozyme
and glucose, at physiologically relevant levels. All spectra have been pre-processed using
a baseline and cosmic spike removal. Again we see more than one order of magnitude im-
provement in the median residual prediction. Up to 6 outliers are present in each PC, which
is approximately the same proportion of the number of spectra in cross-validation that we
observed in figure 6. This data set passed the significance test and returned 37 as the opti-
mal number of PCs. Actual composition is 0.5 mg/mL glucose and 0.5 mg/mL lysozyme.
Predicted concentrations are 0.48 mg/mL and 0.52 mg/mL. The predicted optimal number
of PCs is a local minima in actual RSS, validating the model and pre-processing method.
Preprocessing fails to produce statistical significance in figure 9, leading to a predicted
optimal PC which does not optimize the PCR model. A similar data set to the one in figure 8
is applied to this model using a different Raman spectrum as the unknown and the remaining
39 spectra in a cross-validation model. Preprocessing methods were SG smoothing and 2
derivatives. Residual prediction improves by less than 0.2 orders of magnitude as the number
of PCs are varied. Again selecting the PC with lowest sum of PRESS values (36) as the
optimal number for the model. Actual composition is 1 mg/mL glucose and 1 mg/mL
12
FIG. 8. Artificial tear solution, pre-processed with baseline and cosmic spike removal. PRESS
values of cross-validation using 39 spectra (top) significantly improve with the number of PCs,
and the algorithm identifies 37 PCs for the regression model which is a minima in observed RSS
(bottom).
lysozyme. Predicted concentrations are 0.94 mg/mL and 1.09 mg/mL. The minimum sum
of PRESS does not return a minima in the RSS plot, confirming that this pre-processing
technique is inappropriate for the data set. With our method we seek to contribute a tool
which facilitates the most accurate PCR model available; we have shown in figures 7 and
9 that we can exclude these pre-processing treatments due to their PRESS matrices’ lack
of statistical significance, which manifests as a model that does not perform well when
extended to new spectra.
A general image of the performance provided using pre-processing choice influenced by
statistical significance is shown in figure 10. The pre-processing method for each unknown
spectrum was optimized with the process outlined below:
• Determine the pre-processing techniques which produced statistical significance
• Identify the optimal number of PCs for each significant pre-processing method
• Select the pre-processing method with the lowest sum of PRESS values at the evalu-
ated optimal number of PCs
Allowing our algorithm to select the pre-processing treatment for each individual unknown
file allows us to obtain a median prediction error of 0.26 mg/mL for glucose, and 0.13 mg/mL
for lysozyme. These error values fall either at or below the order of magnitude on which
the solutes are physiologically relevant282427. We are confident that further development
and optimization of our LCW procedure and the statistical selection algorithm will allow
us to bring these values well within the range required for reliable diagnostics.
Differences in the statistical significance trend as a function of the pre-processing method
in the previous examples serve to demonstrate the robustness of our analysis model. Existing
techniques allow the operator to test and assess many pre-processing treatments, but the
results do not provide any measure of the PCR model’s performance when extended to
future spectra. Statistical analysis using our method gives the user this extra information;
current decisions about pre-processing method suitability lack the assurance factor that we
can provide.
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FIG. 9. Artificial tear solution, pre-processed with SG smoothing and 2 derivatives. PRESS values
of cross-validation using 39 spectra (top) neither significantly improve nor worsen with the number
of PCs. Choosing the PC with minimum sum of PRESS values does not minimize observed RSS
(bottom).
FIG. 10. PCR prediction results compared to true concentration, for artificial tear solutions.
Statistical significance is used to optimize the pre-processing method and number of PCs for each
solution.
V. CONCLUSION
Raman spectroscopy is an ideal tool for non-destructive analysis of biofluids, but in-
significant variation between spectra must be compensated for in order to retrieve that
which is diagnostically relevant. A multitude of pre-processing methods and combinations
are available, and the optimal technique varies on a case-to-case basis depending on the
analyte.
Our statistical F-test was applied to analyze variability within PRESS matrices of biofluid
training spectra for PCR. This approach provides a confidence factor that, to the best of
our knowledge, is not present in any other technique. Our algorithm is capable of deter-
mining the optimal pre-processing method, independent of the operator’s experience level.
The analysis technique has proven successful at identifying robustness of pre-processing
techniques in two classes of artificial biofluids: a phantom of tears, and of whole human
blood. Using this technique we demonstrate the ability to repeatedly detect and predict
diagnostically-relevant concentrations of lysozyme in artificial tears. Within the same solu-
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tions we are within one order of magnitude of diagnostically-relevant glucose levels. Using
an enhanced fluidic Raman technique and further algorithm optimization, we forecast that
we will achieve and exceed the resolution necessary for glucose diagnostics in an upcoming
experiment.
This method allows users of all skill levels to rapidly and confidently optimize pre-
processing techniques for their data set, and dedicate time to diagnosis, detection, or data
analysis techniques of biofluid Raman spectroscopy. We propose that this method success-
fully satisfies the need for a dependable, automated and sufficiently generic approach for
PCR; limitations due to omnipresent biological variation are automatically compensated,
allowing for a marked quality increase in robust quantitative analysis of Raman biofluid
spectra.
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